Literature DB >> 21282448

Chromosome-encoded AmpC and CTX-M extended-spectrum β-lactamases in clinical isolates of Proteus mirabilis from Korea.

Wonkeun Song1, Juwon Kim, Il Kwon Bae, Seok Hoon Jeong, Young Hee Seo, Jong Hee Shin, Sook Jin Jang, Young Uh, Jeong Hwan Shin, Mi-Kyung Lee, Kyungwon Lee.   

Abstract

Among 222 Proteus mirabilis clinical isolates collected from 17 hospitals in Korea in 2008, 28 (12.6%) and 8 (3.6%) isolates exhibited extended-spectrum β-lactamase (ESBL) and AmpC phenotypes, respectively. The most common type of ESBL gene identified by PCR and sequencing experiments was bla(CTX-M-14a) (n = 12). The bla(CTX-M-90) (n = 4), bla(CTX-M-15) (n = 3), bla(CTX-M-12) (n = 3), bla(CTX-M-2) (n = 2), bla(CTX-M-14b) (n = 1), bla(TEM-52) (n = 5), and bla(SHV-12) (n = 1) genes were also detected. Eight isolates carried an AmpC β-lactamase gene, such as bla(CMY-2) (n = 6) or bla(DHA-1) (n = 2). All bla genes encoding CTX-M-1- and CTX-M-9-type enzymes and all bla(CMY-2) genes were preceded by ISEcp1-like elements. The bla(CTX-M-2) gene found in two isolates was located on a complex class 1 integron. The bla(DHA-1) gene was preceded by a transcriptional regulator gene and was followed by phage shock protein genes. The bla(CTX-M) genes were located on the chromosome in 21 isolates. A plasmid location for the bla(CTX-M) gene was found in only four isolates: the bla(CTX-M-14a) gene was located on ∼150-kbp IncA/C plasmids in three isolates and on a ∼50-kbp IncN plasmid in one isolate. The bla(TEM-52) gene was located on ∼50-kbp IncN plasmids in all five isolates. The AmpC β-lactamase genes were located on the chromosome in seven of eight isolates; one isolate carried the bla(CMY-2) gene on a ∼150-kbp IncA/C plasmid. Our results show that a chromosomal location of CTX-M ESBL and AmpC β-lactamase genes in P. mirabilis is no longer an unusual phenomenon in hospital environments.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282448      PMCID: PMC3067170          DOI: 10.1128/AAC.01835-09

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Dissemination of an extended-spectrum-beta-lactamase blaTEM-52 gene-carrying IncI1 plasmid in various Salmonella enterica serovars isolated from poultry and humans in Belgium and France between 2001 and 2005.

Authors:  Axel Cloeckaert; Karine Praud; Benoît Doublet; Alessia Bertini; Alessandra Carattoli; Patrick Butaye; Hein Imberechts; Sophie Bertrand; Jean-Marc Collard; Guillaume Arlet; François-Xavier Weill
Journal:  Antimicrob Agents Chemother       Date:  2007-02-26       Impact factor: 5.191

2.  CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.

Authors:  Marco M D'Andrea; Elisabetta Nucleo; Francesco Luzzaro; Tommaso Giani; Roberta Migliavacca; Francesca Vailati; Vesselina Kroumova; Laura Pagani; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

3.  Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.

Authors:  Wonkeun Song; Seok Hoon Jeong; Jae-Seok Kim; Han-Sung Kim; Dong Hun Shin; Kyoung Ho Roh; Kyu Man Lee
Journal:  Diagn Microbiol Infect Dis       Date:  2006-12-15       Impact factor: 2.803

4.  Emergence of Proteus mirabilis carrying the bla metallo-beta-lactamase gene.

Authors:  S Vourli; H Tsorlini; H Katsifa; M Polemis; L S Tzouvelekis; A Kontodimou; A C Vatopoulos
Journal:  Clin Microbiol Infect       Date:  2006-07       Impact factor: 8.067

5.  Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases.

Authors:  L M Aragón; B Mirelis; E Miró; C Mata; L Gómez; A Rivera; P Coll; F Navarro
Journal:  J Antimicrob Chemother       Date:  2008-02-20       Impact factor: 5.790

6.  Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.

Authors:  Francesco Luzzaro; Gioconda Brigante; Marco Maria D'Andrea; Beatrice Pini; Tommaso Giani; Elisabetta Mantengoli; Gian Maria Rossolini; Antonio Toniolo
Journal:  Int J Antimicrob Agents       Date:  2008-12-17       Impact factor: 5.283

7.  Characterization of antimicrobial resistance and class 1 integrons in Enterobacteriaceae isolated from Mediterranean herring gulls (Larus cachinnans).

Authors:  F Gionechetti; P Zucca; F Gombac; C Monti-Bragadin; C Lagatolla; E Tonin; E Edalucci; L A Vitali; L Dolzani
Journal:  Microb Drug Resist       Date:  2008-06       Impact factor: 3.431

8.  Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel.

Authors:  Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; Yehuda Carmeli
Journal:  J Antimicrob Chemother       Date:  2008-05-16       Impact factor: 5.790

9.  Evidence for convergent evolution of CTX-M-14 ESBL in Escherichia coli and its prevalence.

Authors:  Ferran Navarro; Rául-Jesús Mesa; Elisenda Miró; Laura Gómez; Beatriz Mirelis; Pere Coll
Journal:  FEMS Microbiol Lett       Date:  2007-06-07       Impact factor: 2.742

10.  Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

Authors:  Teresa M Coque; Angela Novais; Alessandra Carattoli; Laurent Poirel; Johann Pitout; Luísa Peixe; Fernando Baquero; Rafael Cantón; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

View more
  21 in total

1.  Molecular and biochemical characterization of CTX-M-131, a natural Asp240Gly variant derived from CTX-M-2, produced by a Providencia rettgeri clinical strain in São Paulo, Brazil.

Authors:  Milena Dropa; Barbara Ghiglione; Maria Helena Matté; Livia Carminato Balsalobre; Nilton Lincopan; Glavur Rogério Matté; Gabriel Gutkind; Pablo Power
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

2.  Extended-spectrum β-lactamase-producing Enterobacteriaceae in Cameroonian hospitals.

Authors:  C M Lonchel; P Melin; J Gangoué-Piéboji; M-C O Assoumou; R Boreux; P De Mol
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-08-11       Impact factor: 3.267

3.  Strain diversity of CTX-M-producing Enterobacteriaceae in individual pigs: insights into the dynamics of shedding during the production cycle.

Authors:  Katrine Hartung Hansen; Valeria Bortolaia; Peter Damborg; Luca Guardabassi
Journal:  Appl Environ Microbiol       Date:  2014-08-15       Impact factor: 4.792

4.  Characterization of CTX-M-140, a Variant of CTX-M-14 Extended-Spectrum β-Lactamase with Decreased Cephalosporin Hydrolytic Activity, from Cephalosporin-Resistant Proteus mirabilis.

Authors:  Guo-Bao Tian; Yi-Qi Jiang; Ying-Min Huang; Yun Qin; Lian-Qiang Feng; Xue-Fei Zhang; Hong-Yu Li; Lan-Lan Zhong; Kun-Jiao Zeng; Sandip Patil; Yong Xing; Xi Huang
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

5.  Chromosomal integration and location on IncT plasmids of the blaCTX-M-2 gene in Proteus mirabilis clinical isolates.

Authors:  Sohei Harada; Yoshikazu Ishii; Tomoo Saga; Yuichi Kouyama; Kazuhiro Tateda; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

6.  The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them.

Authors:  Bhaskar Thakuria; Kingshuk Lahon
Journal:  J Clin Diagn Res       Date:  2013-06-01

7.  The spread of KPC-producing Enterobacteriaceae in Spain: WGS analysis of the emerging high-risk clones of Klebsiella pneumoniae ST11/KPC-2, ST101/KPC-2 and ST512/KPC-3.

Authors:  Jesús Oteo; María Pérez-Vázquez; Verónica Bautista; Adriana Ortega; Pilar Zamarrón; David Saez; Sara Fernández-Romero; Noelia Lara; Raquel Ramiro; Belén Aracil; José Campos
Journal:  J Antimicrob Chemother       Date:  2016-08-15       Impact factor: 5.790

8.  Molecular screening of antibiotic-resistant determinants among multidrug-resistant clinical isolates of Proteus mirabilis from SouthWest Nigeria.

Authors:  Olumuyiwa Samuel Alabi; Nuno Mendonça; Olufemi Ezekiel Adeleke; Gabriela Jorge da Silva
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

9.  The antibacterial and antihemolytic activities assessment of zinc oxide nanoparticles synthesized using plant extracts and gamma irradiation against the uro-pathogenic multidrug resistant Proteus vulgaris.

Authors:  Marwa Salah El-Deen Salem; Amira Yahia Mahfouz; Rasha Mohammad Fathy
Journal:  Biometals       Date:  2020-11-26       Impact factor: 2.949

10.  Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal.

Authors:  Aryatara Shilpakar; Mehraj Ansari; Kul Raj Rai; Ganesh Rai; Shiba Kumar Rai
Journal:  Trop Med Health       Date:  2021-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.